Drug Database
CI

ciprofloxacin (Aceoto / Cetraxal / Cetraxal Otico)

✓ Approved

Laboratorios SALVAT · 小分子 · 小分子

什么是 ciprofloxacin?

ciprofloxacin 是一种小分子,由Laboratorios SALVAT研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

商品名Aceoto, Cetraxal, Cetraxal Otico
公司Laboratorios SALVAT
药物类别小分子
给药途径Others
状态Approved

治疗适应症

ciprofloxacin 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsOtitis externa✓ Approved
Ear and labyrinth disordersExternal ear inflammation✓ Approved

相关研究文献

PubMedVeterinary research communications2026-11-19

Antimicrobial non-susceptibility of presumptive commensal Escherichia coli in animals from farms and equestrian centres in Saint Petersburg and the Leningrad Region, Russia: prevalence and farm-level variation.

Bankov Alexander A, Ignatenko Olga O, Azzam Ghaith G, Gureeva Polina P et al.

Antimicrobial resistance in commensal bacteria from farm animals is an important One Health concern; however, data on antimicrobial susceptibility of commensal Escherichia coli in northwest Russia remain limited. A total of 158 non-duplicate presumptive E. coli isolates were obtained from faecal samples collected from horses, sheep, goats, cattle, and reindeer at 11 farms and equestrian centres in Saint Petersburg and the Leningrad Region. Antimicrobial susceptibility was determined using the disk-diffusion method. Zone diameters for ampicillin, ciprofloxacin, tetracycline, cefotaxime, and meropenem were interpreted using the clinical breakpoints in CLSI M100 (34th edition), whereas furagin was interpreted using the disk manufacturer's criteria. All isolates were tested against ampicillin and ciprofloxacin; tetracycline and cefotaxime were tested in 86 isolates and furagin and meropenem in 72 isolates. For this study, non-susceptibility was defined as the combined intermediate and resistant categories (I + R). Among the 86 isolates tested for tetracycline and cefotaxime, 47 (54.7%) and 25 (29.1%) were classified as non-susceptible, respectively. Among the 158 isolates tested for ampicillin and ciprofloxacin, 58 (36.7%) and 44 (27.8%) were classified as non-susceptible, respectively. Of the 72 isolates tested for meropenem, 10 (13.9%) were classified as intermediate, and none as resistant. All 72 isolates tested against furagin were classified as susceptible according to the disk manufacturer's interpretive criteria. Marked variation in non-susceptibility was observed between farms. After accounting for clustering within farms, neither age nor sex was significantly associated with ampicillin or ciprofloxacin non-susceptibility. These findings provide baseline data for the sampled farms and equestrian facilities in Saint Petersburg and the Leningrad Region and underscore the value of farm-level surveillance of antimicrobial susceptibility in commensal E. coli.

PMID 43052464
阅读全文 →
PubMedBMC infectious diseases2026-11-19

Changes in the clinical distribution and antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital before and after the COVID-19 pandemic.

Yang Yan Y, Long Chunyan C, He Ye Y, Huang Tao T et al.

The widespread use of broad-spectrum antibiotics and adjustments in hospital infection control measures during the COVID-19 pandemic may have reshaped the epidemiological characteristics and resistance patterns of Klebsiella pneumoniae (KP). Currently, there are limited longitudinal data on the distribution and the dynamic resistance profiles of KP in Chinese tertiary hospitals across different phases of the pandemic. Therefore, this study aimed to analyze these changes to advance antibiotic stewardship and hospital infection control. KP strains isolated from clinical specimens at a tertiary hospital in Chongqing were analyzed for three periods: 2017-2019 (pre‑pandemic), 2020-2022 (mid‑pandemic), and 2023-2025 (post‑pandemic). We focused on the epidemiological profile and changes in the antibiotic resistance of KP. Data were analyzed using GraphPad Prism 10.1.2 and WHONET 5.6 software. In total, 883 KP strains were isolated, accounting for 20.8% of Gram-negative bacteria during the same period. The isolation rate of KP significantly increased in the post-pandemic phase (P < 0.05). The isolation rates of carbapenem-resistant KP (CRKP) were 3.0%, 12.2%, and 5.0% in the pre-pandemic, mid-pandemic, and post-pandemic periods, respectively, showing significant differences (P < 0.05). The isolation rates of extensively drug-resistant KP (XDR-KP) were 2.4%, 8.3%, and 4.7% in the pre-pandemic, mid-pandemic, and post-pandemic periods, respectively. The top three sources of specimens were sputum (75.5%), secretions (7.8%), and urine (6.6%). The age distribution of patients with CRKP and carbapenem-susceptible KP (CSKP) showed a significant difference (P < 0.05). The resistance rates of KP to various antibiotics increased during the mid-pandemic phase and declined in the post-pandemic phase. Compared to the pre-pandemic phase, the imipenem resistance rate increased more than threefold in the mid-pandemic phase, and then decreased in the post-pandemic phase. There were significant changes in the resistance rates of KP to ceftazidime, cefepime, ciprofloxacin, imipenem, and trimethoprim-sulfamethoxazole (P < 0.05). The transition from the COVID-19 pandemic was closely associated with changes in the isolation rate and drug resistance of KP. Hospitals should continuously monitor high-risk populations and key prevention and control points to guide rational clinical drug use and the prevention and control of multidrug-resistant bacteria.

PMID 43052809
阅读全文 →
PubMedVestnik otorinolaringologii2026-11-18

[Use of Sextaphag in the treatment of chronic tubotympanic purulent otitis media during an exacerbation in adult patients].

Kryukov A I AI, Gurov A V AV, Shadrin G B GB, Lapenko E G EG

To evaluate the clinical and microbiological efficacy, safety, and tolerability of Sextaphage Polyvalent Pyobacteriophage in the treatment of chronic tubotympanic suppurative otitis media in adults, and to compare its outcomes with ciprofloxacin therapy and combined treatment. This non-interventional clinical study included 60 patients aged 18 to 70 years with an exacerbation of chronic suppurative otitis media. The patients were divided into three groups of 20 subjects each. Group 1 received ciprofloxacin 0.3% ear drops; Group 2 received Sextaphage Polyvalent Pyobacteriophage; and Group 3 received a combination of ciprofloxacin and Sextaphage. The treatment duration was 10 days. Clinical symptom dynamics, severity of otorrhea, otomicroscopic findings, and bacteriological examination results of middle ear discharge were assessed. The most frequently isolated pathogens were Pseudomonas aeruginosa and Staphylococcus aureus, each detected in 26.6% of cases. By day 10 of treatment, cessation of otorrhea was observed in 90% of patients in Group 1, 85% of patients in Group 2, and 95% of patients in Group 3. Microbiological efficacy was confirmed in 44 of 60 patients. No adverse events or side effects associated with Sextaphage administration were reported. Sextaphage Polyvalent Pyobacteriophage demonstrated clinical and microbiological efficacy comparable to ciprofloxacin, along with a favorable safety profile. Combined therapy was associated with the most pronounced clinical effect, supporting phage therapy as a promising therapeutic approach for chronic suppurative otitis media in adults.

PMID 43046734
阅读全文 →
PubMedLuminescence : the journal of biological and chemical luminescence2026-11-18

A Dual-Functional Fluorescent Probe Based on Nitrogen and Phosphorus Co-Doped Carbon Quantum Dots for the Detection of Hg2+ and Ciprofloxacin.

Wang Teng T, Yin Huan H, Xu Fuhang F, Lin Jianyuan J et al.

The widespread overuse of antibiotics and excessive discharge of heavy metal ions pose a serious threat to the human ecological environment and food safety, rendering the development of efficient and sensitive detection methods highly significant. This paper synthesizes nitrogen and phosphorus co-doped carbon quantum dots (N,P-CQDs) using citric acid, o-phenylenediamine, and phosphoric acid as precursors via a solvothermal method and applies them to the detection of ciprofloxacin (CIP) and mercury ions (Hg2+). The results demonstrated that the as-prepared N,P-CQDs exhibited superior optical properties and dual sensing capabilities. CIP induced fluorescence enhancement of N,P-CQDs through hydrogen bonding, with a limit of detection (LOD) of 0.053 μM over the linear range of 0.8-100 μM, whereas Hg2+ caused fluorescence quenching of N,P-CQDs via a static quenching mechanism, with an LOD of 0.010 μM over the linear range of 0.7-8 μM. Furthermore, this sensor has been successfully applied to the determination of CIP and Hg2+ in environmental water and milk, with a recovery rate of 95.6%-104.0%, verifying its good practicality in the trace detection of CIP and Hg2+. This study provides a valuable reference for the development of portable and low-cost multifunctional fluorescence probes for environmental and food safety detection.

PMID 43046668
阅读全文 →
PubMedMedScience2026-11-18

Emerging gene and stem cell therapies for hereditary hearing loss: from molecular correction to regenerative reconstruction.

Cheng Yixin Y, Fu Siqi S, Qi Jieyu J, Chai Renjie R

Hearing loss is among the most common sensory impairments globally and remains a significant unmet clinical challenge. Current rehabilitative approaches, such as hearing aids and cochlear implants, provide partial functional compensation but fail to restore the structural and physiological integrity of the cochlea. This review summarizes progress in therapeutic development targeting key deafness-associated genes, including OTOF, GJB2, and SLC26A4, highlighting the rationale, current clinical evidence, and major translational challenges. We further discuss the potential of combining gene therapy with stem cell-based approaches to promote inner ear regeneration and restore sensorineural function. Emerging technologies such as CRISPR/Cas, adeno-associated virus, and induced pluripotent stem cell-derived otic progenitors have opened new avenues for causal correction and tissue reconstruction. Integrated therapeutic models that combine gene or stem cell therapy with cochlear implants are reshaping the treatment paradigm from symptom management to biological repair. Advances in gene editing, gene delivery, and stem cell technologies are establishing these approaches as promising treatments for hereditary hearing loss, with ongoing progress expected to accelerate clinical translation despite remaining challenges in delivery efficiency, immune responses, ethics, and long-term efficacy. Collectively, these advances mark a pivotal step toward personalized and regenerative interventions for hereditary hearing loss.

PMID 43045834
阅读全文 →
PubMedMediterranean journal of hematology and infectious diseases2026-11-18

Pathogen Distribution, Antimicrobial Resistance, and Mortality in Febrile Neutropenia among Adults with Hematological Malignancies: A Single-Center Cohort Study.

Bulut Rukiyye R, Erayman İbrahim İ, Yaman Ceren Eryılmaz CE, Kandemir Bahar B et al.

Febrile neutropenia (FN) remains a major infectious complication in patients with hematological malignancies, and local epidemiological data are essential for guiding management. To characterize the pathogen distribution, antimicrobial resistance profile, and antimicrobial exposures in FN and to evaluate factors associated with 28-day infection-related mortality. This retrospective single-center cohort included adults with hematological malignancies who developed FN at a tertiary university hospital between April 2022 and September 2024. The primary cohort comprised 156 patients with 226 classical FN episodes. Patient-level analyses were used for clinical outcomes and multivariable analyses, whereas episode-level analyses were used for microbiological and antimicrobial exposure data. Among 73 clinically significant isolates, Gram-negative bacteria predominated (76.7%), mainly Escherichia coli (45.2%) and Klebsiella spp. (24.7%). Meropenem resistance was detected in 6.1% of E. coli and 77.8% of Klebsiella spp. isolates; ceftazidime-avibactam resistance was 3.0% and 33.3%, respectively. Concurrent resistance to both ciprofloxacin and levofloxacin was detected in 75.8% of E. coli and 94.4% of Klebsiella spp. isolates. No MRSA was recovered, while glycopeptides were administered in 38.9% of classical FN episodes. Infection-related mortality was 10.3% and 28-day all-cause mortality was 12.8%. No variable was significantly associated with infection-related mortality in the exploratory multivariable analysis. Gram-negative pathogens predominated, with substantial meropenem resistance among Klebsiella spp. Continuous local resistance surveillance and antimicrobial stewardship are essential. Larger multicenter studies are needed to better define factors associated with infection-related mortality.

PMID 43048228
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多ciprofloxacin